| Type | Title | Date Released | |
|---|---|---|---|
SCHEDULE 13G | BIGGER CAPITAL FUND L P (Filed by) | ||
8-K | Dermata Therapeutics Announces First Participant Enrolled in Clinical Trial for Tome Clearing Treatment | ||
424B3 | SHARE RESALE REGISTRATION | Shares: 6,919,560 | ||
EFFECT | Form EFFECT | ||
S-3 | SHARE RESALE REGISTRATION EFFECTIVE, DATED 2026-10-20 | ||
4 | PROEHL GERALD T (Reporting) | ||
4 | Van Hoose Kyri K. (Reporting) | ||
25-NSE | Form 25-NSE | ||
8-K | Dermata Therapeutics Announces $3.4 Million Private Placement | ||
10-Q | Form 10-Q | ||
8-K | Dermata Therapeutics Reports Q2 2026 Financial Results and Announces Launch Date for Tome™ Foundational Treatment | ||
8-K | Dermata Therapeutics Announces Commercial Launch Date for Tome Foundational Treatment |